REMODULINPRO.COM: Keyword Density Checker

Total words: 3228 | 2-word phrases: 859 | 3-word phrases: 943 | 4-word phrases: 967

PAGE INFO

Title	Try to keep the title under 60 characters (74 characters) Remodulin (parenteral treprostinil) \| Injection Prostacyclin Class Therapy
Description	Try to keep the meta description between 50 - 160 characters (205 characters) Healthcare professional site for Remodulin (parenteral treprostinil), a prostacyclin class therapy offered in both subcutaneous and intravenous delivery systems. Learn about pump options for your patients.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	in patients with	6	0.64%
2	remodulin is a	4	0.42%
3	blood stream infections	4	0.42%
4	the risk of	4	0.42%
5	pulmonary arterial hypertension	3	0.32%
6	hepatic or renal	3	0.32%
7	treatment with remodulin	3	0.32%
8	an external infusion	3	0.32%
9	external infusion pump	3	0.32%
10	group 1 to	3	0.32%
11	of clinical deterioration	3	0.32%
12	1 to diminish	3	0.32%
13	to diminish symptoms	3	0.32%
14	symptoms associated with	3	0.32%
15	associated with exercise	3	0.32%
16	diminish the rate	3	0.32%
17	the rate of	3	0.32%
18	rate of clinical	3	0.32%
19	diminish symptoms associated	3	0.32%
20	customer service at	3	0.32%
21	risk of blood	3	0.32%
22	wwwremodulinprocom or call	3	0.32%
23	or call customer	3	0.32%
24	call customer service	3	0.32%
25	of blood stream	3	0.32%
26	full prescribing information	3	0.32%
27	intravenous iv infusions	2	0.21%
28	13 vs 5	2	0.21%
29	vs 5 vasodilatation	2	0.21%
30	and precautions chronic	2	0.21%

#	Keyword	Frequency	Density
1	of blood stream infections	3	0.31%
2	call customer service at	3	0.31%
3	wwwremodulinprocom or call customer	3	0.31%
4	an external infusion pump	3	0.31%
5	group 1 to diminish	3	0.31%
6	1 to diminish symptoms	3	0.31%
7	to diminish symptoms associated	3	0.31%
8	diminish symptoms associated with	3	0.31%
9	symptoms associated with exercise	3	0.31%
10	risk of blood stream	3	0.31%
11	diminish the rate of	3	0.31%
12	the rate of clinical	3	0.31%
13	rate of clinical deterioration	3	0.31%
14	or call customer service	3	0.31%
15	5 vasodilatation 11 vs	2	0.21%
16	vs 5 vasodilatation 11	2	0.21%
17	13 vs 5 vasodilatation	2	0.21%
18	pain 13 vs 5	2	0.21%
19	vasodilatation 11 vs 5	2	0.21%
20	11 vs 5 edema	2	0.21%
21	vs 3 and hypotension	2	0.21%
22	vs 5 edema 9	2	0.21%
23	5 edema 9 vs	2	0.21%
24	edema 9 vs 3	2	0.21%
25	9 vs 3 and	2	0.21%
26	rash 14 vs 11	2	0.21%
27	3 and hypotension 4	2	0.21%
28	and hypotension 4 vs	2	0.21%
29	2 drug interactions remodulin	2	0.21%
30	drug interactions remodulin dosage	2	0.21%
31	interactions remodulin dosage adjustment	2	0.21%
32	remodulin dosage adjustment may	2	0.21%
33	14 vs 11 jaw	2	0.21%
34	25 vs 16 nausea	2	0.21%
35	18 rash 14 vs	2	0.21%
36	sc or iv remodulin	2	0.21%
37	other common adverse events	2	0.21%
38	≥3 more than placebo	2	0.21%
39	more than placebo seen	2	0.21%
40	than placebo seen with	2	0.21%

#	URL	Whois	Check
1	https://cdn.bfldr.com/9KOBNM5X/as/qt3n339p5vbrwf5ccf34sn7/Privacy_Statement_UTC__Websites	Whois	bfldr.com
2	https://www.unither.com/terms	Whois	unither.com
3	https://www.unither.com/contact.html	Whois	unither.com